All coverage
COVID-19 vaccine blood clots: Should you be concerned?
By Sean Jackson
White House writes off Johnson & Johnson vaccine after string of production failures
By Sarah Owermohle, Adam Cancryn & Erin Banco
L.A. County prepping to resume administering Johnson & Johnson vaccine
By Luke Money & Colleen Shalby
U.S. ends J&J COVID-19 vaccine pause; shots to resume immediately
By Julie Steenhuysen & Manas Mishra
Emergent BioSolutions halts operations at its Baltimore plant, where J.&J. doses were ruined, at the F.D.A.'s request ...
By Sheryl Gay Stolberg
Johnson & Johnson COVID vaccine: Pause lifted by FDA, use to resume
By Karen Weintraub & Elizabeth Weise
CDC panel voted to resume J&J COVID-19 shots paused for clot concerns
By Tina Hesman Saey
FDA ends Johnson & Johnson vaccine pause - POLITICO
By Sarah Owermohle, David Lim & Erin Banco
Johnson & Johnson Vaccine: U.S. Lifts Pause : Coronavirus Updates
By Laurel Wamsley
Federal Inspectors Fear More Vaccines Were Exposed to Contamination (Published 2021)
By Sharon LaFraniere, Chris Hamby & Sheryl Gay Stolberg
Johnson & Johnson Vaccine Will Be Available Again Soon
By Denise Grady, Julie Bosman & Noah Mercer Weiland
The public's concerns over the Johnson & Johnson coronavirus vaccine are widespread, Post-ABC poll finds
By Scott Clement & Amy Goldstein